Description:

PRESENTER: Cristina Sampaio, MD, PhD
TOPIC: Huntington Disease on the road for successful clinical trials and therapeutic advancement

Cristina Sampaio is Professor of Clinical Pharmacology and Therapeutics, senior member of the Movement Disorders Clinic, Department of Neurology and Principal Investigator at Instituto de Medicina Molecular,Universidade de Lisboa, Portugal. Until very recently she was also a member of both the Committee of Proprietary Medicinal Products and the Scientific Advice Working Party at the European Medicines Agency (EMA) that provides guidance on the quality and non-clinical/clinical safety and efficacy regarding new medicinal products, including those for orphan diseases like HD. Dr. Sampaio’s main research interests are the design and methodology of clinical studies in neurodegenerative disorders, pharmacoepidemiology, and evidence-based medicine. She joined CHDI in 2011.